For decades, the ACT and the SAT have been the gatekeepers of college admissions, purporting to measure a student's aptitude in core subjects and producing a score that can mold a person's future. Now ...

CAMBRIDGE, Mass. - Enveric Biosciences (NASDAQ:ENVB) announced Thursday that its lead drug candidate EB-003 activates two signaling pathways associated with antidepressant and anti-anxiety effects, ...

Phase 3 clinical trial data has been a success. COMP360 is the first traditional psychedelic to consistently deliver a highly statistically significant outcome. Results included maintaining a ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

LONDON - Compass Pathways plc (NASDAQ:CMPS) will report new clinical data on Tuesday from its ongoing Phase 3 trials evaluating COMP360, a synthetic psilocybin formulation being studied for ...

More university admissions offices are now accepting an alternative to the SAT and ACT that focuses on classical philosophy and literature. It’s called the Classical Learning Test, and it’s based on ...